生殖线向疫苗概念:艾滋病毒临床前和临床试验的概述和更新
1Department of Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Current HIV research
|February 24, 2025
概括
开发一种有效的HIV-1疫苗需要产生广泛中和抗体 (bNAbs). 目前的策略旨在引导原始B细胞成熟为bNAb产生细胞,这是疫苗疗效的关键一步.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 病毒学 病毒学
背景情况:
- 有效的HIV-1疫苗必须诱导广泛中和抗体 (bNAbs),以向HIV包膜糖蛋白 (Env) 的保存区域.
- 尽管经过数十年的研究,通过免疫接种引起bNAbs仍然是一个重大挑战.
- 艾滋病毒Env蛋白质优先结合成熟的bNAbs,而不是他们的幼稚的生殖线前体,阻碍了bNAb的诱导.
研究的目的:
- 讨论开发针对生殖线的新型Env免疫原体,旨在吸引bNAb前体B细胞.
- 审查这些生殖系向免疫原体的体内评估.
- 探索指导B细胞受体 (BCR) 成熟的策略,以广泛中和抗体形式.
主要方法:
- 设计Env衍生的蛋白质,专门针对bNAbs的生殖线前体.
- 在活体中评估向生殖线的免疫原活性,激活原始B细胞.
- 对B细胞成熟和分化策略的评估.
主要成果:
- 针对生殖线的Env免疫原体在体内激活相应的原始B细胞.
- 目前仅仅针对生殖线的免疫原是不足以引导B细胞成熟成为bNAb产生细胞的.
- 为了使B细胞成熟,似乎需要进一步免疫特定的异质Envs.
结论:
- 针对生殖线的Env免疫原体的开发是朝着引起bNAbs.的前途有前途的一步.
- 目前正在积极研究指导生殖线前体BCRs快速成熟的策略.
- 克服B细胞成熟的挑战对于推动HIV-1疫苗开发至关重要.
相关概念视频
01:30Cancer Vaccines
325
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
325
01:16In-vitro Mutagenesis
13.7K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
13.7K